Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Obesity 13Sexual Dysfunction, Physiological 6Breast Neoplasms 5Overweight 4Neoplasms 4Mucositis 3Endometrial Neoplasms 3Cancer-related Fatigue 3Sexual Dysfunctions, Psychological 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Motor Activity 2Leukemia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Constipation 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Pediatric Obesity 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1

Interventions

mirogabalin 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × CIPN × Other × Clear all
NCT06711978 2024-12-02

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

Pusan National University Yangsan Hospital

Phase NA Not yet recruiting
66 enrolled
BreastOther

CIPN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡